Revenues of Autolus Therapeutics plc from 30 Sep 2016 to 31 Mar 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary: Autolus Therapeutics plc quarterly and annual Revenues in USD history and change rate from 30 Sep 2016 to 31 Mar 2025.
Autolus Therapeutics plc Revenues for the quarter ending 31 Mar 2025 was $8,982,000, a 11% decline year-over-year.
Autolus Therapeutics plc annual Revenues for 2024 was $10,120,000, a 496% increase from 2023.
Autolus Therapeutics plc annual Revenues for 2023 was $1,698,000.
Autolus Therapeutics plc annual Revenues for 2019 was $2,908,000, a 107% increase from 2018.
Source SEC data: View on sec.gov

Revenues, Trailing 12 Months (USD)

Revenues, Quarterly (USD)

Revenues, YoY Quarterly Change (%)

Revenues, Annual (USD)

Revenues, YoY Annual Change (%)

Autolus Therapeutics plc Quarterly Revenues (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025		$8,982,000	-$1,109,000	-11%	01 Jan 2025	31 Mar 2025	10-Q	08 May 2025	2025	Q1
Q1 2024		$10,091,000			01 Jan 2024	31 Mar 2024	10-Q	08 May 2025	2025	Q1
Q1 2021		$269,000	-$69,000	-20%	01 Jan 2021	31 Mar 2021	6-K	06 May 2021	2021	Q1
Q2 2020	$1,237,000	$293,000	-$45,000	-13%	01 Apr 2020	30 Jun 2020	6-K	06 Aug 2020	2020	Q2
Q1 2020	$1,282,000	$338,000	-$1,626,000	-83%	01 Jan 2020	31 Mar 2020	6-K	06 May 2021	2021	Q1
Q4 2019	$2,908,000	$309,000	+$13,000	+4.4%	01 Oct 2019	31 Dec 2019	20-F	03 Mar 2020	2019	FY
Q3 2019	$2,895,000	$297,000	-$10,000	-3.3%	01 Jul 2019	30 Sep 2019	6-K	07 Nov 2019	2019	Q3
Q2 2019	$2,905,000	$338,000	-$105,000	-24%	01 Apr 2019	30 Jun 2019	6-K	06 Aug 2020	2020	Q2
Q1 2019	$3,010,000	$1,964,000			01 Jan 2019	31 Mar 2019	6-K	07 May 2020	2020	Q1
Q4 2018		$296,000	+$65,000	+28%	01 Oct 2018	31 Dec 2018	20-F	03 Mar 2020	2019	FY
Q3 2018		$307,000			01 Jul 2018	30 Sep 2018	6-K	07 Nov 2019	2019	Q3
Q2 2018		$443,000			01 Apr 2018	30 Jun 2018	6-K	08 Aug 2019	2019	Q2
Q4 2017		$231,000			01 Oct 2017	31 Dec 2017	20-F	25 Feb 2019	2019	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2024	$10,120,000	+$8,422,000	+496%	01 Jan 2024	31 Dec 2024	10-K	20 Mar 2025	2024	FY
2023	$1,698,000			01 Jan 2023	31 Dec 2023	10-K	20 Mar 2025	2024	FY
2019	$2,908,000	+$1,501,000	+107%	01 Jan 2019	31 Dec 2019	20-F	03 Mar 2020	2019	FY
2018	$1,407,000	-$286,000	-17%	01 Oct 2017	30 Sep 2018	20-F	03 Mar 2020	2019	FY
2017	$1,693,000	+$481,000	+40%	01 Oct 2016	30 Sep 2017	20-F	03 Mar 2020	2019	FY
2016	$1,212,000			01 Oct 2015	30 Sep 2016	20-F	25 Feb 2019	2019	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.